Cargando…
TRPM1 Autoantibodies in Melanoma Patients Without Self-Reported Visual Symptoms
PURPOSE: Melanoma-associated retinopathy (MAR) is a paraneoplastic syndrome associated with cutaneous malignant melanoma (CMM). Visual symptoms include night blindness, photopsia, and reduced-contrast sensitivity. An abnormal ERG b-wave and the presence of anti-bipolar cell autoantibodies, including...
Autores principales: | Duvoisin, Robert M., Ren, Gaoying, Haley, Tammie L., Taylor, Matthew H., Morgans, Catherine W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532695/ https://www.ncbi.nlm.nih.gov/pubmed/31117125 http://dx.doi.org/10.1167/iovs.19-26775 |
Ejemplares similares
-
Autoantibodies in Melanoma-Associated Retinopathy Recognize an Epitope Conserved Between TRPM1 and TRPM3
por: Duvoisin, Robert M., et al.
Publicado: (2017) -
Serum TRPM1 Autoantibodies from Melanoma Associated Retinopathy Patients Enter Retinal ON-Bipolar Cells and Attenuate the Electroretinogram in Mice
por: Xiong, Wei-Hong, et al.
Publicado: (2013) -
Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy
por: Varin, Juliette, et al.
Publicado: (2020) -
TRPM3 Expression in Mouse Retina
por: Brown, R. Lane, et al.
Publicado: (2015) -
Correction: Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy
Publicado: (2020)